Concepedia

Author

Julie E. Bauman

University of PittsburghORCID

Also Known As

Bauman, Julie, Frank Detterbeck, J Bauman, J E Bauman, J. Bauman, J.E. Bauman, Julie Bauman, Julie E Bauman, Julie E. Bauman, Peter Miller

308

Publications

10.3K

Citations

46

H-Index

100

Concepts

All Affiliations

University of PittsburghUPMC Hillman Cancer CenterUniversity of ArizonaUniversity of Arizona Cancer CenterJohns Hopkins University
JE

About

Julie E. Bauman is an author at University of Pittsburgh specializing in medicine, oncology, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

20

31

1.6K

2

Health Sciences

12

13

857

3

Public Health

2

2

37

4

Biochemistry

1

1

13

5

Biomolecular Engineering

1

1

13

Julie E. Bauman

×

84

Publications

5.3K

Citations

42

H-Index

YearCitations

E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx— ECOG-ACRIN Cancer Research Group

Shanthi Marur, Shuli Li, Anthony J. Cmelak,

Journal of Clinical Oncology

2017

486

Phase II Study of Daily Sunitinib in FDG-PET–Positive, Iodine-Refractory Differentiated Thyroid Cancer and Metastatic Medullary Carcinoma of the Thyroid with Functional Imaging Correlation

Laurie L. Carr, David A. Mankoff, Bernardo Goulart,

Clinical Cancer Research

2010

417

Drug repurposing from an academic perspective

Tudor I. Oprea, Julie E. Bauman, Cristian Bologa,

Drug Discovery Today Therapeutic Strategies

2011

363

Cisplatin and Radiotherapy With or Without Erlotinib in Locally Advanced Squamous Cell Carcinoma of the Head and Neck: A Randomized Phase II Trial

Renato Martins, Upendra Parvathaneni, Julie E. Bauman,

Journal of Clinical Oncology

2013

201

Genetic landscape of metastatic and recurrent head and neck squamous cell carcinoma

Matthew L. Hedberg, Gerald Goh, Simion I. Chiosea,

Journal of Clinical Investigation

2015

199

Circulating exosomes measure responses to therapy in head and neck cancer patients treated with cetuximab, ipilimumab, and IMRT

Marie‐Nicole Theodoraki, Saigopalakrishna S. Yerneni, William E. Gooding,

OncoImmunology

2019

164

A Prospective Phase 2 Trial of Reirradiation With Stereotactic Body Radiation Therapy Plus Cetuximab in Patients With Previously Irradiated Recurrent Squamous Cell Carcinoma of the Head and Neck

John A. Vargo, Robert L. Ferris, James Ohr,

International Journal of Radiation Oncology*Biology*Physics

2015

147

Molecular Characterization of Apocrine Salivary Duct Carcinoma

Simion I. Chiosea, Lindsay Williams, Christopher Griffith,

The American Journal of Surgical Pathology

2015

126

Prevention of Carcinogen-Induced Oral Cancer by Sulforaphane

Julie E. Bauman, Yan Zang, Malabika Sen,

Cancer Prevention Research

2016

114

Treatment of Recurrent Squamous Cell Carcinoma of the Skin With Cetuximab

Julie E. Bauman, Keith D. Eaton, Renato Martins

Archives of Dermatology

2007

111

Page 1